Rhetorical Analysis Of Pharmaceutical Innovation Can We Live Forever

The U.S. Health system spends a higher portion of its gross domestic product than any other country but ranks 37 out of 191 countries according to its performance.” (WHO, 2000, p. 1) Progression in the United States has not kept up with the advances in other wealthy nations dealing with the population health. Disease and chronic disability report almost 50% of America health problem (JAMA, 2013).

Bell continued to interview a journalist named Greg Critser, who authored the book “Generation RX,” which is about the relationship between America and pharmaceuticals. He exclaims that drug companies advertise their product so much that it internalizes inside individuals that the drugs they’re selling are good and not poison, then he continued where the drug is somewhat of a poison where it kills another thing off to benefit another. Pharmaceutical companies also lobby the political side of their ambitions to cover up the negative side of their

The Dying of the Light is an article by Dr. Craig Bowron that captures the controversy surrounding the role of medication in prolonging life. The author describes that many medical advancements have become a burden to particularly elderly patients who in most instances are ready to embrace the reality of death. Dr. Bowron believes that dying in these modern times has become a tiring and unnatural process. “Everyone wants to grow old and die in his or her sleep, but the truth is most of us will die in pieces,” Bowron notes (Bowron). The article does not advocate for euthanasia or the management of health care costs due to terminal or chronic illness. Bowron faults humanity for not embracing life and death with dignity as it was in the past.

The twenty-first century has seen pharmaceutical companies grow in unprecedented size and strength. Due to the unprecedented growth the larger pharmaceutical companies have gained leverage and power in the prescription drug industry, but they lack innovation to market and they seek ways to help the business continue to increase its profits. The pharmaceutical industry was once ethically sound and was a valuable player in the development of human health. However, overtime with the lack of innovation pharmaceutical companies are becoming an unethical market that exploits patients, doctors and anyone else it can to increase its profitability. With eyes only on profitability this can create a hazard for patients because there

Although Canada has always been considered a small country, its achievements in medicine are far from small. They have greatly benefited Canada and improved the country’s way of life. In fact, Canadian physician Dr. Frederick Banting discovered insulin to treat diabetes. Also, Michael smith developed site-directed mutagenesis to alter and identify genes. Lastly, doctors at Toronto Hospital For Sick Children produced Pablum to treat rickets. These notable breakthroughs in Canadian medicine have positively impacted Canadian life.

Christopher Wanjek, author of Smart Pills: The Truth About Cognitive Enhancing Drugs, a columnist for Live Science and a health and science writer informs readers over the strict and malicious side effects of smart pills. Throughout the article the author illustrates the merit and ethics behind the use of a drug that can become a popular norm further in the future from advocates, such as college students. However, the author feels very appalled by this and continues to further elaborate on this by exclaiming that,“Ritalin is riddled with side effects, such as heart problems, and Adderall adds all the more to the mix, such as the risk of chemical dependency”( Christopher Wanjek, December 9, 2008, Para.2). In addition, to harmful affects the

Australia’s wealthy economy conveys advanced, up to date medical and surgical technology, whereas Portugal’s technology has not been updated since 1988. Furthermore, Australia has more hospitals, 741 public and 525 private compared to Portugal’s 89 public and 82 private hospitals. With Australia’s advanced technology and abundance of hospitals, comes a greater life expectancy of 83 for females and 78 for males compared to Portugal’s life expectancy of 78.2.

United States take pride in many things: world’s largest economy, strong military power, internationally acclaimed institutions, great cultural diversity, endless entertainment from Hollywood to Major League Baseball, and more. Unfortunately, health care did not make it into the list. It is quite unsettling to accept that 2010 health data for industrialized countries placed United States in the last place in almost every criteria. U.S. health care spending had reached $7,538 per capita which was far more than any other country, doubling the OECD median of $2,995 (Squire, 2). In the analysis of five-year survival and mortality rate for various forms of cancer, the data showed that the outcomes of Americans did not perform any better than

There are 196 countries with healthcare systems across the world… Canada’s healthcare system is ranked 30th overall. Most critics keep health care related debates to the small scope of Canada and the USA. However, neither the USA nor Canada’s systems are ranked in the top 25 for overall efficiency (The Patient Factor). In order for Canada’s healthcare system to improve, there must be changes made in regards to major problems; financial aspects, timely access, and the doctor shortages. “Evidence shows that the best healthcare systems in the world are founded on a strong primary care system” (TheStar.com). Perhaps Canada can learn from these countries that are ranked higher, and provide more efficient care to Canadian citizens.

In this paper, the USA healthcare system is being compared to the Canadian healthcare system. The U.S. health system has been described as the most competitive, heterogeneous, and inefficient, fragmented, and advanced system of care in the

Cambridge Sciences Pharmaceuticals (CSP) is an international healthcare company based in Cambridge, Massachusetts. The firm focuses on developing, manufacturing and marketing products that treat metabolic disorders, gastrointestinal diseases, immune deficiencies, as well as other chronic medical conditions. In 2008, CSP received its Food and Drug Administration (FDA) approval for its newest prescription drug, Metabical. Metabical is a drug that offers moderately overweight adults a medically proven, effective method to reach a desirable weight to improve their overall health by shedding ten to thirty pounds.

Lorex Pharmaceuticals recently gained FDA approval to market and sell a new product called Linatol. This memo will address the need to select a target amount to which each 10-ounce bottle of Linatol will be filled. The analysis of several target fill rates was conducted to determine the one that maximizes the contribution per case, therefore generating the maximum revenue for Lorex Pharmaceuticals. This ideal fill rate will allow more bottles to be sold at the full retail price of $186 and limit the under filled

Written about the structure and culture of biomedical heath care and a society that is attempting to prolong aging, Medicare funding, funding and development of research, and today’s definition of standard care, Sharon Kaufman brings to light the many dilemmas posed to the American health care system. Her ethnographic story, Ordinary Medicine: Extraordinary Treatments, Longer Lives and Where to Draw the Line reveals the booming biomedical research and clinical trials industry, the power held by Medicare and private insurance, and a rapidly changing standard of care once a medical treatment is considered reimbursable. This leads to systematic changes in the standard of care result in a massive amount of pressure being placed upon doctors, patients and families to make an ethically and medically sound decision in refusing or accepting therapy. Kaufman exposes the driving forces behind the expansion of biomedicine, society’s response to the growing industry on a personal and bureaucratic level.

In our day and age as we know it, there have been astounding advancements in medicine. The average life expectancy has risen. People are being educated in issues that surround a healthy life style. As a society, we are trying to increase our life span and defeat death. While people are following strict

He sets out the number of guidance that meant to assist in establishing the building of which lifespan can become ‘eternal’. (Vitruvius, 1960) However, in modern, ever changing society, Vitruvian stance of permanence becomes partly invalid and problematic.